Bayrak, Ö. Et Al. 2024. Metformin - an oral antidiabetic agent- improves chemotherapy efficacy in colorectal cancer by inhibiting hypoxia- induced metabolic adaptation. MOLECULAR ONCOLOGY , vol.18, no.S1 , 431.

Bayrak, Ö., Kemahlı, M. B., Kasap, M. E., Bayrak, S., & Başbınar, Y., (2024). Metformin - an oral antidiabetic agent- improves chemotherapy efficacy in colorectal cancer by inhibiting hypoxia- induced metabolic adaptation. MOLECULAR ONCOLOGY , vol.18, no.S1, 431.

Bayrak, Özge Et Al. "Metformin - an oral antidiabetic agent- improves chemotherapy efficacy in colorectal cancer by inhibiting hypoxia- induced metabolic adaptation," MOLECULAR ONCOLOGY , vol.18, no.S1, 431, 2024

Bayrak, Özge Et Al. "Metformin - an oral antidiabetic agent- improves chemotherapy efficacy in colorectal cancer by inhibiting hypoxia- induced metabolic adaptation." MOLECULAR ONCOLOGY , vol.18, no.S1, pp.431, 2024

Bayrak, Ö. Et Al. (2024) . "Metformin - an oral antidiabetic agent- improves chemotherapy efficacy in colorectal cancer by inhibiting hypoxia- induced metabolic adaptation." MOLECULAR ONCOLOGY , vol.18, no.S1, p.431.

@article{article, author={Özge Bayrak Et Al. }, title={Metformin - an oral antidiabetic agent- improves chemotherapy efficacy in colorectal cancer by inhibiting hypoxia- induced metabolic adaptation}, journal={MOLECULAR ONCOLOGY}, year=2024, pages={431} }